Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation

British Journal of Haematology

Volumn 130, Issue 1, 2005, Pages 113-120

  Cugno, Massimo ^a   Agostoni, Piergiuseppe ^a   Mari, Daniela ^a   Meroni, Pier Luigi ^a   Gregorini, Luisa ^a   Bussotti, Maurizio ^a   Anguissola, Gian Battista ^a   Donatelli, Francesco ^a   Nussberger, Jürg ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Bradykinin; Endothelium; Exercise; Heart failure; Ischaemia

Indexed keywords

BLOOD CLOTTING FACTOR 12A; BRADYKININ; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; INTERLEUKIN 6; SPIRONOLACTONE; TUMOR NECROSIS FACTOR RECEPTOR 2; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERY DIAMETER; ARTERY OCCLUSION; ARTERY OCCLUSION TEST; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; BRACHIAL ARTERY; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; EXERCISE; EXERCISE TEST; FEMALE; FOREARM BLOOD FLOW; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; ISCHEMIA; MALE; NEW YORK HEART ASSOCIATION CLASSIFICATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; BRACHIAL ARTERY; BRADYKININ; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; EXERCISE; FACTOR XIIA; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-6; ISCHEMIA; LISINOPRIL; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TISSUE PLASMINOGEN ACTIVATOR; VASODILATION; VON WILLEBRAND FACTOR;

EID: 22144469860     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05569.x     Document Type: Article

References (32)

1. Agnoletti, L., Curello, S., Bachetti, T., Malacarne, F., Gaia, G., Comini, L., Volterrani, M., Bonetti, P., Parrinello, G., Cadei, M., Grigolato, P.G. & Ferrari, R. (1999) Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation, 100, 1983-1991.
2. Brown, N.J., Gainer, J.V., Murphey, L.J. & Vaughan, D.E. (2000) Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation, 102, 2190-2196.
3. Celermajer, D.S., Sorensen, K.E., Gooch, V.M., Spiegelhalter, D.J., Miller, O.I., Sullivan, I.D., Lloyd, J.K. & Deanfield, J.E. (1992) Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340, 1111-1115.
4. Cheng, C.P., Onishi, K., Ohte, N., Suzuki, M. & Little, W.C. (1998) Functional effects of endogenous bradykinin in congestive heart failure. Journal of the American College of Cardiology, 31, 1679-1686.
5. Chong, A.Y., Blann, A.D., Patel, J., Freestone, B., Hughes, E. & Lip, G.Y.H. (2004) Endothelial dysfunction and damage in congestive heart failure. Relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation, 110, 1800-1804.
6. Cleland, J.G.F., Witte, K. & Thackray, S. (2000) Bradykinin and ventricular function. European Heart Journal Supplements, 2 (Suppl. H), H20-H29.
7. Corretti, M.C., Anderson, T.J., Benjamin, E.J., Celermajer, D., Charbonneau, F., Creager, M.A., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D., Vallance, P., Vita, J. & Vogel, R. (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. Journal of the American College of Cardiology, 39, 257-265.
8. Gruden, N.L., Witherow, F.N., Webb, D.J., Fox, K.A. & Newby, D.E. (2004) Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Arteriosclerosis Thrombosis and Vascular Biology, 24, 1043-1048.
9. Cugno, M., Cicardi, M. & Agostoni, A. (1994) Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid. Journal of Allergy and Clinical Immunology, 93, 870-876.
10. Cugno, M., Agostoni, P., Brunner, H.R., Gardinali, M., Agostoni, A. & Nussberger, J. (2000) Plasma bradykinin levels in human chronic congestive heart failure. Clinical Science, 99, 461-466.
11. Cugno, M., Mari, D., Meroni, P.L., Gronda, E., Vicari, F., Frigerio, M., Coppola, R., Bottasso, B., Borghi, M.O. & Gregorini, L. (2004) Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation. British Journal of Haematology, 126, 85-92.
12. Duncan, A.M., Kladis, A., Jennings, G.L., Dart, A.M., Esler, M. & Campbell, D.J. (2000) Kinins in humans. American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 278, R897-R904.
13. Fichtischerer, S., Rossig, L., Breuer, S., Vasa, M., Dimmeler, S. & Zeiher, A.M. (2001) Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation, 104, 3023-3025.
14. Francis, G.S., Benedict, C., Johnstone, D.E., Kirlin, P.C., Nicklas, J., Liang, C.S., Kubo, S.H., Rudin-Toretsky, E. & Yusuf, S. (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation, 82, 1724-1729.
15. Fujii, M., Wada, A., Tsutamoto, T., Ohnishi, M., Isono, T. & Kinoshita, M. (2002) Bradykinin improves left ventricular diastolic function under long-term angiotensin-converting enzyme inhibition in heart failure. Hypertension, 39, 952-957.
16. Guazzi, M., Marenzi, G., Alimento, M., Contini, M. & Agostoni, P. (1997) Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation, 95, 1930-1936.
17. James, F.W. & Donaldson, V.H. (1981) Decreased exercise tolerance and hypertension in severe hereditary deficiency of plasma kininogens. Lancet, 1, 889.
18. Kaplan, A.P., Joseph, K. & Silverberg, M. (2002) Pathways for bradykinin formation and inflammatory disease. Journal of Allergy and Clinical Immunology, 109, 195-209.
19. Kelly, R.A. & Smith, T.W. (1997) Cytokines and cardiac contractile function. Circulation, 95, 778-781.
20. Levine, B., Kalman, J., Mayer, L., Fillit, H.M. & Packer, M. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New England Journal of Medicine, 323, 236-241.
21. Liu, Y.H., Yang, X.P., Mehta, D., Bulagannawar, M., Scicli, G.M. & Carretero, O.A. (2000) Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats. American Journal of Physiology - Heart and Circulatory Physiology, 278, H507-H514.
22. Mannucci, P.M. & Coppola, R. (1999) Von Willebrand Factor. In: Laboratory Techniques in Thrombosis. A Manual (ed. by J. Jespersen, R.M. Bertina & F. Haverkate), pp. 115-119. Kluwer Academic Publishers, Boston, MA.
23. Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A. & Agostoni, A. (1998) Plasma bradykinin in angio-oedema. Lancet, 351, 1693-1697.
24. Paton, C.M., Nagelkirk, P.R., Coughlin, A.M., Cooper, J.A., Davis, G.A., Hassouna, H., Pivarnik, J.M. & Womack, CJ. (2004) Changes in von Willebrand factor and fibrinolysis following a post-exercise cool-down. European Journal of Applied Physiology, 92, 328-333.
25. Prado, G.N., Taylor, L., Zhou, X., Ricupero, D., Mierke, D.F. & Polgar, P. (2002) Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. Journal of Cellular Physiology, 193, 275-286.
26. Sabelis, L.W., Senden, P.J., Fijnheer, R., de Groot, P.G., Huisveld, I.A., Mosterd, W.L. & Zonderland, M.L. (2004) Endothelial markers in chronic heart failure: training normalizes exercise-induced vWF release. European Journal of Clinical Investigation, 34, 583-589.
27. Schmaier, A.H. (2003) The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction. American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 285, R1-R13.
28. Su, J.B., Barbe, F., Houel, R., Guyene, T.T., Crozatier, B. & Hittinger, L. (1998) Preserved vasodilator effect of bradykinin in dogs with heart failure. Circulation, 98, 2911-2918.
29. Testa, M., Yeh, M., Lee, P., Fanelli, L., Loperfido, F. & Berman, J.W. (1996) Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. Journal of the American College of Cardiology, 28, 964-971.
30. Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J.B. & Mann, D.L. (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). Journal of the American College of Cardiology, 27, 1201-1206.
31. Vasan, R.S., Sullivan, L.M., Roubenoff, R., Dinarello, C.A., Harris, T., Benjamin, E.J., Sawyer, D.B., Levy, D., Wilson, P.W. & D'Agostino, R.B. (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation, 107, 1486-1491.
32. Witherow, F.N., Helmy, A., Webb, D.J., Fox, K.A. & Newby, D.E. (2001) Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Circulation, 104, 2177-2181.